Skip to main content Skip to footer

Eligibility and availability of COVID-19 vaccine booster

Who is eligible for a booster and additional dose of the COVID-19 vaccine?

Pfizer

The Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) have authorized a booster of the Pfizer COVID-19 vaccine for all individuals 5 years of age and older, five months after the last dose in the initial series. In addition, individuals ages 50 and older may choose to receive a second booster four months after the first booster.

Moderna

The FDA and CDC have also authorized a booster of the Moderna COVID-19 vaccine for all individuals 18 years of age and older, five months after the last dose in the initial series. Please note that the Moderna booster is a half dose. In addition, individuals ages 50 and older may choose to receive a second booster four months after the first booster.

Johnson & Johnson

The CDC recommends that individuals who received a J&J vaccine now receive a booster of an mRNA vaccine (Pfizer or Moderna) two months after their initial dose. In addition, a second booster of an mRNA vaccine may be administered four months after the first booster.

Moderately and severely immunocompromised individuals:

  • Immunocompromised individuals who received Moderna and Pfizer should receive a third dose as part of the primary series 28 days later and then a booster three months later. Immunocompromised individuals ages 12 and older may choose to receive a second booster four months after the first booster for a total of five shots.
  • The CDC is now recommending that immunocompromised individuals who received the J&J vaccine should get an additional shot of either Pfizer or Moderna as part of the primary series before getting a booster. As such, immunocompromised individuals who received J&J as their initial dose should now receive a second dose of an mRNA vaccine (Pfizer or Moderna) as part of the primary series 28 days later and then a booster of an mRNA vaccine (Pfizer or Moderna) two months later. Immunocompromised individuals ages 12 and older may choose to receive a second mRNA booster four months after the first booster for a total of four shots.
  • Immunocompromised individuals ages 5-11 should get a booster three months after the last dose of the initial series for a total of four shots.

Moderate or severely immunocompromised is defined as the following:

  • Active treatment for solid tumor and hematologic malignancies
  • Receipt of solid-organ transplant and taking immunosuppressive therapy
  • Receipt of CAR-T-cell or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
  • Moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome)
  • Advanced or untreated HIV infection
  • Active treatment with high-dose corticosteroids (i.e., ≥20mg prednisone or equivalent per day), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor-necrosis (“TNF”) blockers, and other biologic agents that are immunosuppressive or immunomodulatory
  • Any other moderately to severely immunocompromising condition deemed as such by the treating provider

Of important note: The FDA and CDC also confirmed that eligible individuals can receive a different COVID-19 vaccine as a booster from the one they initially received.

We continue to monitor for new developments and will provide updates if a booster is recommended for additional populations.

More information on how eligible individuals can receive their COVID-19 vaccine booster can be found here.

Who is eligible for a booster of the COVID-19 vaccine?

Moderately and severely immunocompromised individuals

The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have authorized a third dose of Pfizer’s and Moderna’s COVID-19 vaccines for moderately and severely immunocompromised individuals ages 12 and older at least 28 days following the second dose.

This includes people who have:

  • Been receiving active cancer treatment for tumors or cancers of the blood
  • Received an organ transplant and are taking medicine to suppress the immune system
  • Received a stem cell transplant within the last two years or are taking medication to suppress the immune system
  • Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
  • Advanced or untreated HIV infection
  • Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response
  • Received CAR-T cell therapy
{6}

We will provide updates if a booster is recommended for additional populations

Please schedule your first and second dose if you haven't yet.

Those eligible can call 1.844.BSW.VACC to book an appointment or self-schedule on MyBSWHealth.com and the app. 

Booster scheduling for ages 5-11 is now available.

Pharmacies have limited supply.

*Available for patients 12 and up. Pediatric vaccinations for those 5-11 are not provided at this location.

Find a vaccine site near you today using the CDC's vaccine finder

The most important thing is to get vaccinated, whether at a Baylor Scott & White location or another vaccine site.

Eligible individuals can self-schedule on MyBSWHealth.com and the app, or call 1.844.BSW.VACC to book an appointment. 

Appointments are preferred. Limited walk-ins may be available based on vaccine availability.

As a reminder, Pfizer is authorized for individuals ages 12 and older, and Moderna is authorized for individuals ages 18 and older.

Location

Walk-in hours

Vaccine

Austin/Round Rock: BSW – Pharmacy #201
425 University Blvd., Suite 165, Round Rock, TX 78665

Monday – Friday
10 a.m. – 4 p.m.

Moderna

Baylor Scott & White Pharmacy – Belton #229
309 Lake Rd Ste B, Belton, TX 76513

Monday – Friday
10 a.m. – 4 p.m.

Pfizer

Baylor Scott & White Pharmacy – College Station #276
1296 Arrington Rd., Suite 200, College Station, TX 77845

Monday – Friday
10 a.m. – 4 p.m.

Moderna

Baylor Scott & White Pharmacy – Dallas #101
3600 Gaston Ave., Dallas, TX 75246
(Inside of Baylor University Medical Center, located on the first floor of Barnett Tower)

Tuesdays and Wednesdays
9 a.m. – 5 p.m.

Moderna

Baylor University Medical Center on Hall Street
1208 Hall Street, Dallas, TX 75204

Tuesdays
7 a.m. – 4 p.m.

Pfizer

Baylor Scott & White Pharmacy – Fort Worth #102
1250 8th Ave., Suite 125, Fort Worth, Texas 76104

Fridays
9 a.m. – 5 p.m.

Moderna

 

Baylor Scott & White Pharmacy – Garland #106
7217 Telecom Pkwy, Suite 190, Garland, TX 75044

Mondays
9 a.m. – 4 p.m.

Pfizer

Baylor Scott & White Pharmacy – Grapevine #107
1600 W College St., Suite 110, Grapevine, TX 76051

Tuesdays and Wednesdays
9 a.m. – 5 p.m.

Pfizer

Baylor Scott & White Pharmacy – Killeen #231
2500 Cross Dr, Killeen, TX 76543

Monday – Friday
10 a.m. – 4 p.m.

Pfizer

Baylor Scott & White Pharmacy – McKinney #105
5236 W University Dr., Suite 1900, McKinney, Texas 75071

Wednesdays
9 a.m. – 5 p.m.

Moderna

Baylor Scott & White Pharmacy – Salado #232
3525 FM2484, Salado, TX 76571

Monday – Friday
10 a.m. – 4 p.m.

Pfizer

Baylor Scott & White Pharmacy – Southlake #112
925 E. Southlake Blvd., Suite 120, Southlake, TX 76092

Thursdays and Fridays
9 a.m. – 4 p.m.

Pfizer

Baylor Scott & White Pharmacy – Temple #226
1901 SW HK Dodgen Loop, Building 300 (first floor), Temple, TX 76502

Monday – Friday
10 a.m. – 4 p.m.

Pfizer

Baylor Scott & White Pharmacy – Temple/Canyon Creek #227
937 Canyon Creek Dr., Temple, TX 76502

Monday – Friday
10 a.m. – 4 p.m.

Pfizer and Moderna

Baylor Scott & White Pharmacy – Temple/CDM #228
1605 S 31st Street, Suite 19, Temple, TX 76508

Monday – Friday
10 a.m. – 4 p.m.

Pfizer

Baylor Scott & White Pharmacy – Temple/Northside #230
514 W Adams Ave, Temple, TX 76501

Monday  –Friday
10 a.m. – 4 p.m.

Pfizer

Baylor Scott & White Pharmacy – Waco #254
50 Hillcrest Medical Blvd., Suite 200-1, Waco, TX 76712

Tuesdays
9 a.m. – 5 p.m.

Moderna

Baylor Scott & White Pharmacy – Waxahachie #110
2460 N Interstate 35E, Professional Plaza I, Suite 155, Waxahachie, TX 75165

Tuesdays
9 a.m. – 5 p.m.

Pfizer and Moderna

Frequently Asked Questions

Booster and third dose eligibility and facts

Pfizer
The Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) have authorized a booster of the Pfizer COVID-19 vaccine for all individuals 5 years of age and older, five months after the last dose of the initial series. In addition, individuals age 50 and older may choose to receive a second booster four months after the first booster.

Moderna
The FDA and CDC have also authorized a booster of the Moderna COVID-19 vaccine for all individuals 18 years of age and older, five months after the last dose of the initial series. Please note that the Moderna booster is a half dose. In addition, individuals age 50 and older may choose to receive a second booster four months after the first booster.

Johnson & Johnson
The CDC recommends that individuals who received a J&J vaccine now receive a booster of an mRNA vaccine (Pfizer or Moderna) two months after their initial dose.

Moderately and severely immunocompromised individuals:

  • Immunocompromised individuals who received Moderna and Pfizer should receive a third dose as part of the primary series 28 days later and then a booster three months later. Immunocompromised individuals ages 12 and older may choose to receive a second booster four months after the first booster for a total of five shots.
  • The CDC is now recommending that immunocompromised individuals who received the J&J vaccine should get an additional shot of either Pfizer or Moderna as part of the primary series before getting a booster. As such, immunocompromised individuals who received J&J as their initial dose should now receive a second dose of an mRNA vaccine (Pfizer or Moderna) as part of the primary series 28 days later and then a booster of an mRNA vaccine (Pfizer or Moderna) two months later. Immunocompromised individuals ages 12 and older may choose to receive a second mRNA booster four months after the first booster for a total of four shots.
  • Immunocompromised individuals ages 5-11 should get a booster three months after the last dose of the initial series for a total of four shots.

Moderate or severely immunocompromised is defined as the following:

  • Active treatment for solid tumor and hematologic malignancies
  • Receipt of solid-organ transplant and taking immunosuppressive therapy
  • Receipt of CAR-T-cell or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
  • Moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome)
  • Advanced or untreated HIV infection
  • Active treatment with high-dose corticosteroids (i.e., ≥20mg prednisone or equivalent per day), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor-necrosis (“TNF”) blockers, and other biologic agents that are immunosuppressive or immunomodulatory
  • Any other moderately to severely immunocompromising condition deemed as such by the treating provider

Of important note: The FDA and CDC also confirmed that eligible individuals can receive a different COVID-19 vaccine as a booster from the one they initially received.

We continue to monitor for new developments and will provide updates if a booster is recommended for additional populations.

More information on how eligible individuals can receive their COVID-19 vaccine booster can be found here.

  • Individuals ages 12 years and older who are moderately or severely immunocompromised may choose to receive a second booster dose using an mRNA COVID-19 vaccine at least 4 months after the first booster dose
  • Adults ages 50 years and older who are not moderately or severely immunocompromised may choose to receive a second booster dose using an mRNA COVID-19 vaccine at least 4 months after the first booster dose
  • Individuals ages 18–49 years who are not moderately or severely immunocompromised and who received Janssen COVID-19 Vaccine may receive a second booster dose using an mRNA COVID-19 vaccine at least 4 months after the first Janssen booster dose

For those who are immunocompromised, please note the following:

  • Immunocompromised individuals who received Moderna and Pfizer should receive a third dose as part of the primary series 28 days later and then a booster three months later. Immunocompromised individuals ages 12 and older may choose to receive a second booster four months after the first booster for a total of five shots.
  • The CDC is now recommending that immunocompromised individuals who received the J&J vaccine should get an additional shot of either Pfizer or Moderna as part of the primary series before getting a booster. As such, immunocompromised individuals who received J&J as their initial dose should now receive a second dose of an mRNA vaccine (Pfizer or Moderna) as part of the primary series 28 days later and then a booster of an mRNA vaccine (Pfizer or Moderna) two months later. Immunocompromised individuals ages 12 and older may choose to receive a second mRNA booster four months after the first booster for a total of four shots.
  • Immunocompromised individuals ages 5-11 should get a booster three months after the last dose of the initial series for a total of four shots.
Yes, pregnant women are eligible for the booster. Pregnant women should receive a booster vaccination when its time to get one.
According to the CDC, although COVID-19 vaccination for older adults remains effective in preventing severe disease, recent data suggest vaccination is less effective at preventing infection or milder illness with symptoms over time. Clinical trial data show a booster shot may result in increased effectiveness compared to primary vaccination.
The FDA and CDC recently updated their guidance and confirmed that eligible individuals can receive a different COVID-19 vaccine as a booster from the one they initially received.
No. There have been no new side effects reported in patients who received a booster of the vaccine.
No. It is not necessary to get an antibody test before getting a booster.
No, however, the CDC is urging everyone to stay up to date on their COVID-19 vaccines. This includes immunocompromised people who are eligible for additional doses and those who are eligible for a booster.

Getting a booster at Baylor Scott & White

Those eligible for a booster can self-schedule on MyBSWHealth.com and the app, or call the vaccine line (1.844.BSW.VACC) to schedule an appointment.

Appointments are preferred. Walk-in availability is extremely limited.
If you have your CDC vaccination card from your first two doses or the single-shot J&J vaccine, please bring that with you.
Yes. If you cannot find your vaccination card, we will provide you with a new one with the date of the booster. You can request a copy of your immunization record from the Texas Department of State Health Services (DSHS) site.

If you received your COVID-19 vaccine at a Baylor Scott & White facility, you can also access and print your immunization record, including the lot number, through MyBSWHealth.com using these instructions
Please speak with your doctor to see whether your specific condition or medication you may be taking qualifies you for recommending the booster.
Baylor Scott & White only has vaccine supply allocated to certain locations conveniently located throughout our service areas. Please click here to view our available locations and scheduling options. Please note that walk-in availability at our sites is extremely limited and appointments are preferred.

If you do receive your booster outside of BSW, please be sure to send a picture of your CDC card to your BSW provider through the MyBSWHealth messaging portal.
Scroll To Top